全科团队式管理在轻中度阿尔茨海默病患者中的应用

Abstract
Figure/Table
References (21)
Related Citation (15)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of general practice team management in patients with mild to moderate Alzheimer′s disease (AD). Methods A total of 96 patients with mild to moderate AD who were followed up by Shangrao People′s Hospital and Beimen Street Community Health Service Center, Xinzhou District, Shangrao City from January 2016 to December 2019 were selected as the research objects, and were divided into experimental group and the control group according to the random number table method, each with 48 cases. The experimental group was managed by a general practice team, and the control group was managed by routine self-management. Analyze the dopezil hydrochloride and memantine hydrochloride medication rates, mini-mental state examination (MMSE) scores, activities of daily living (ADL) scores, hospital admission rates, and family caregivers′ Zarit burden questionnaire (ZBI) between the two groups of patients score. Results After 1 year of follow-up, the rate of medication in the experimental group was higher than that of the control group, and the difference was statistically significant (P<0.05). After intervention, the MMSE score and ADL score of the experimental group were higher than those of the control group, and the hospital admission rate and ZBI score were lower than the control group, the differences were statistically significant (P＜0.05).Conclusion General practice team management for patients with mild to moderate AD can improve treatment compliance, better disease control, and reduce the burden on family caregivers with better results.

Key words： Alzheimer′s disease General practice team management Treatment compliance Effect evaluation Family caregiver burden

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Yuan-ya
	ZHENG Wen
	LIAO Ling
	YANG Shui-feng
	WU Cheng-hui
	TAO Ming-hua
	HUANG Chen

Cite this article:

ZHANG Yuan-ya,ZHENG Wen,LIAO Ling, et al. Application of general practice team management in patients with mild to moderate Alzheimer′s disease[J]. 中国当代医药, 2021, 28(34): 69-72.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I34/69

[1]	岳玲，王涛，肖世富.阿尔茨海默病诊断与治疗研究进展[J].张江科技评论，2019（1）：10-12.
[2]	Robinson M，Lee BY，Hanes FT.Recent Progress in Alzheimer′s Disease Research，Part 2：Genetics and Epidemiology[J].J Alzheimers Dis，2018，61（1）：459.
[3]	李伟梅.阿尔茨海默病患者功能障碍与家庭照护者负担的相关性[J].中国现代医生，2015，53（17）：138-139.
[4]	Thyrian JR，Hertel J，Wucherer D，et al.Effectiveness and Safety of Dementia Care Management in Primary Care：A Randomized Clinical Trial[J].JAMA Psychiatry，2017，74（10）：996-1004.
[5]	Reisberg B，Shao Y，Golomb J，et al.Comprehensive，Individualized，Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease：A Randomized Controlled Trial[J].Dement Geriatr Cogn Disord，2017，43（1-2）：100-117.
[6]	严飞，陈阳，杨蓉，等.轻度认知功能障碍的社区干预措施研究进展[J].中国全科医学，2018，21（12）：1402-1407.
[7]	王俊，陈旭，陈碧华.社区轻中度阿尔茨海默病的全科团队式管理效果分析[J].中华老年心脑血管病杂志，2015，17（7）：676-678.
[8]	郝立晓，贾建国，韩璎，等.主观认知下降社区管理研究现状[J].中国全科医学，2016，19（35）：4285-4290.
[9]	李婧，王美荣，邵爽，等.北京市全科医生对痴呆社区照顾知识与态度研究[J].中国医药导报，2019，16（9）：185-188.
[12]	周小炫，谢敏，陶静，等.简易智能精神状态检查量表的研究和应用[J].中国康复医学杂志，2016，31（06）：694-696.
[13]	Wade DT，Collin C.The Barthel ADL Index：a standard measure of physical disability?[J].Int Disabil Stud，1988，10（2）：64-67.
[10]	Sperling RA，Aisen PS，Beckett LA，et al.Toward defining the preclinical stages of Alzheimer′s disease：recommendations from the National Institute on Aging-Alzheimer′s Association workgroups on diagnostic guidelines for Alzheimer′s disease[J].Alzheimers Dement，2011，7（3）：280-292.
[11]	Li H，Jia J，Yang Z.Mini -Mental State Examination in Elderly Chinese：A Population-Based Normative Study[J].J Alzheimers Dis，2016，53（2）：487-496.
[14]	Teri L，Logsdon RG，Mccurry SM，et al.Translating an Evidence-based Multicomponent Intervention for Older Adults With Dementia and Caregivers[J].Gerontologist，2020，60（3）：548-557.
[15]	Briggs R，Kennelly SP，O′ Neill D.Drug treatments in Alzheimer′s disease[J].Clin Med（Lond），2016，16（3）：247-253.
[16]	Chen Z，Yang X，Song Y，et al.Challenges of Dementia Care in China[J].Geriatrics（Basel），2017，2（1）：7.
[17]	Ashford J W.Treatment of Alzheimer′s Disease：Trazodone，Sleep，Serotonin，Norepinephrine，and Future Directions[J].J Alzheimers Dis，2019，67（3）：923-930.
[18]	Quail Z，Carter MM，Wei A，et al.Management of cognitive decline in Alzheimer′s disease using a non-pharmacological intervention program：A case report[J].Medicine （Baltimore），2020，99（21）：e20128.
[19]	Reuben DB，Tan ZS，Romero T，et al.Patient and Caregiver Benefit From a Comprehensive Dementia Care Program：1-Year Results From the UCLA Alzheimer′s and Dementia Care Program[J].J Am Geriatr Soc，2019，67（11）：2267-2273.
[20]	张海娜，王美荣，陈小垒，等.基于德尔菲法的痴呆社区管理工作内容构建研究[J].中国全科医学，2020，23（16）：2072-2079.
[21]	胡国娣，向梅，张学平，等.综合性认知康复训练在阿尔茨海默病患者中应用的效果评价[J].中国现代医生，2020，58（12）：98-101.